| __timestamp | Bio-Techne Corporation | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 106352000 | 9216000000 |
| Thursday, January 1, 2015 | 144969000 | 8296000000 |
| Friday, January 1, 2016 | 162364000 | 10044000000 |
| Sunday, January 1, 2017 | 188462000 | 11560000000 |
| Monday, January 1, 2018 | 210850000 | 10558000000 |
| Tuesday, January 1, 2019 | 240515000 | 9351000000 |
| Wednesday, January 1, 2020 | 255497000 | 8933000000 |
| Friday, January 1, 2021 | 298182000 | 8284000000 |
| Saturday, January 1, 2022 | 349103000 | 7952000000 |
| Sunday, January 1, 2023 | 366887000 | 8200000000 |
| Monday, January 1, 2024 | 389335000 | 8480000000 |
Unleashing insights
In the ever-evolving landscape of pharmaceuticals and biotechnology, cost efficiency remains a pivotal factor for success. Teva Pharmaceutical Industries Limited and Bio-Techne Corporation, two industry titans, showcase contrasting trajectories in their cost of revenue from 2014 to 2023.
Teva, a global leader in generic medicines, has seen its cost of revenue fluctuate, peaking in 2017 with a 25% increase from 2014. However, by 2022, Teva's costs had decreased by approximately 14%, reflecting strategic cost management.
Conversely, Bio-Techne, a key player in the biotech sector, has consistently increased its cost of revenue, growing by over 250% from 2014 to 2023. This growth underscores Bio-Techne's expansion and investment in innovation.
As we look to the future, understanding these trends offers valuable insights into the financial strategies of these industry leaders.
Pfizer Inc. vs Bio-Techne Corporation: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Regeneron Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Dr. Reddy's Laboratories Limited
Gross Profit Analysis: Comparing Teva Pharmaceutical Industries Limited and Bio-Techne Corporation
Teva Pharmaceutical Industries Limited or Bio-Techne Corporation: Who Invests More in Innovation?
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Telix Pharmaceuticals Limited's Expenses
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Bausch Health Companies Inc.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Mesoblast Limited
Cost of Revenue Comparison: Viatris Inc. vs Bio-Techne Corporation
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and Bio-Techne Corporation
Cost of Revenue Trends: Bio-Techne Corporation vs Corcept Therapeutics Incorporated
Cost of Revenue Trends: Bio-Techne Corporation vs MorphoSys AG